Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 * - Concepedia

Concepedia

Publication | Closed Access

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

1.3K

Citations

0

References

1994

Year

B. Fisher, Joseph P. Costantino, Carol Redmond, E R Fisher, D. Lawrence Wickerham, Walter M. Cronin

JNCI Journal of the National Cancer Institute

Abstract

Tamoxifen treatment for breast cancer should continue. In addition, the relative risk of endometrial cancer observed in B-14 tamoxifen-treated patients is consistent with the twofold relative risk used in the initial risk-benefit computation for the NSABP breast cancer prevention trial.